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In order to determine the sensitivity and reliability of antirotaviral fecal immunoglobulin A (IgA) as an
indicator of rotavirus reinfection, the antibody responses to rotavirus of 44 infants with severe rotavirus
gastroenteritis recruited on admission to a hospital were studied. Feces were collected daily during
hospitalization and weekly thereafter, and sera were obtained every 4 months, for 6 to 32 months (median, 17
months). Antirotaviral IgG, IgA, and IgM were measured by enzyme immunoassay in all samples. Rotavirus
antigen, rotavirus-neutralizing antibody, and total IgA were measured in feces. The results showed that use of
an IgA index (ratio of specific IgA to total IgA) was unnecessary to identify copro-IgA conversion to rotavirus.
The other markers of rotavirus infection tested showed a high level of predictive accuracy of coproconversion
in rotavirus-neutralizing antibody. Copro-IgM, serum IgM, and virus in feces were insensitive measures of
neutralizing antibody coproconversion. Seroconversion in IgG or IgA was detected in 46% of neutralizing
coproconversions. The most sensitive marker, present in 92% of neutralizing coproconversions, was antiro-
taviral fecal IgA conversion. This correlation of fecal IgA with fecal neutralizing antibody suggests that
coproconversions in IgA represent true elevations in antirotaviral IgA with neutralizing capacity. A
coproconversion in IgA appears to indicate genuine rotavirus infection. Copro-IgA conversions in feces
collected weekly are likely to be more sensitive markers of rotavirus reinfection than are seroconversion and
virus detection combined in epidemiological studies of acute diarrhea in children and in rotavirus vaccine trials.
Rotaviruses are a major cause of severe acute diarrhea in
humans and animals. These viruses infect the mature epithe-
lial cells on the villi of the small intestine (14), and animal
studies have identified a local intestinal antibody as the most
important factor in passive host protection against rotaviral
disease (24, 30). Vaccine programs have evaluated orally
administered, live rotaviruses as vaccine candidates. These
animal rotaviruses appear to be naturally attenuated in
humans but share antigenic characteristics with human rota-
viruses (31, 34). Clinical trials of these vaccine candidates
have shown that the protection conferred against disease is
serotype specific (9, 19), suggesting that successful vaccina-
tion may require controlled exposure of young children to
rotavirus of more than one serotype.
During vaccine trials, predictions of efficacy on the basis
of monitoring of seroresponses by complement fixation,
enzyme immunoassay (EIA) for immunoglobulin G (IgG)
and IgA, and neutralizing antibody have been less than the
vaccine efficacy measured by clinical protection against
diarrhea (32). Thus, it appears that serum immune responses
may not be the most sensitive measure of vaccine take, at
least when animal (heterologous) vaccines are given.
It is likely that antibodies produced by cells in the gut
mucosa in response to infection and secreted into the gut
lumen are the best markers of an immune response. How-
ever, the antibody response of the intestine in vaccinated
children has not been studied extensively (20, 33). In natural,
presumably primary, severe acute rotavirus infection, we
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have shown that seroconversions in antirotaviral IgM and
IgG are sensitive indicators of an immune response and
reflect the response in duodenal fluid. Both fecal IgA and
serum IgA showed a high predictive accuracy of duodenal
IgA levels at 1 and 4 months postinfection, but the stronger
correlation of duodenal IgA was with fecal IgA (16). Thus,
the measurement of copro-IgA most accurately reflects the
duodenal antibody response to primary rotavirus infection.
The aim of this study was to analyze in detail the ongoing
intestinal and serum antibody responses to rotavirus in
infants and young children monitored longitudinally for at
least 1 year following severe acute rotavirus infection. In
particular, the study was designed to determine the rele-
vance and reliability of changes in rotavirus-specific copro-
IgA, rotavirus-neutralizing coproantibody, and serum IgG,
IgM, and IgA as sensitive markers of secondary rotavirus
infection. To this end, rotavirus antibody levels were mea-
sured in stools collected weekly and in serum collected at
least every 4 months. Measurement of rotavirus-specific
antibodies in feces by using EIA detected many significant
increases in copro-IgA and neutralizing coproantibody not
accompanied by virus excretion or by seroconversions. It is
postulated that IgA coproconversion may be a reliable and
sensitive marker of rotavirus reinfection in young children.
MATERIALS AND METHODS
Patients and samples. Patients were 44 children, 3 weeks to
39 months old, admitted with acute rotavirus diarrhea to the
infectious diseases ward of the Royal Children's Hospital,
Melbourne, Australia, between April 1984 and September
1985. The clinical, demographic, and laboratory findings of
these children while hospitalized have been described pre-
viously (16). Approval for the study was given by the Human
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1368 COULSON ET AL.
Ethics Committees of the Royal Children's Hospital and the
World Health Organization. Informed signed consent was
obtained from the parents of the children prior to enrollment
in the study.
Blood and fecal specimens were collected from each child
at 2 to 7 days (median, 5.5 days), 24 to 66 days (median, 33.5
days), and 100 to 282 days (median, 122 days) after the onset
of symptoms and at approximately 4-month intervals there-
after. Although collection intervals varied from child to
child, for each individual child, blood and feces were col-
lected on the same day. Additional fecal specimens were
collected daily while each child was in the hospital and at 7-
to 10-day intervals from 39 (89%) children for more than 1
year and 13 (30%) children for more than 2 years. Overall,
the children were monitored for 6 to 32 months (median, 17
months) after the onset of symptoms. All families were in
telephone contact every 3 weeks with a research nurse
(J.S.L.), who visited their homes each month, at which time
a clinical history of the child was obtained. All of the
mothers were requested to keep a diary of the health of the
child, and approximately one-third did so for the duration of
the study. Parents were asked to contact J.S.L. or a pedia-
trician (K.G.) immediately when episodes of acute diarrhea
occurred. Extra fecal specimens were collected during diar-
rheal episodes. Additional blood samples were obtained 2 to
6 weeks following the diarrhea in 39 (35%) of the episodes.
Feces were refrigerated on collection and stored at -70°C
within 4 h, if obtained in the hospital. Feces collected at
home every 7 to 10 days by mothers were immediately
frozen at -4°C in domestic freezers, collected each month,
transferred to the hospital in a car freezer, and then stored at
-70°C. A 10% (wt/vol) suspension of feces (0.1 g in 1.0 ml)
in phosphate-buffered saline (pH 7.2) was prepared on the
day of assay for antiviral antibody. After centrifugation of
the suspension at 2,000 x g for 10 min, the resulting
supernatant was kept on ice until tested and then was stored
immediately at -70°C. This supernatant was assayed for
rotavirus antigen by monoclonal EIA with EDTA treatment
(13). Following Lyphogel concentration, the supernatant
was examined for rotavirus by electron microscopy (EM) as
previously described (13).
Viruses and cells. Human rotavirus strains used in all
assays included RV-4 (serotype 1), RV-5 (serotype 2), and
RV-3 (neonatal; serotype 3) previously adapted to culture in
our laboratory (1); Wa (serotype 1) and ST-3 (neonatal;
serotype 4) were provided by R. G. Wyatt (Bethesda, Md.);
KU (serotype 1) was provided by T. Kutsuzawa (Japan).
Simian rotavirus SA11 was supplied by H. Malherbe (San
Antonio, Tex.).
All viruses were propagated in MA104 cells in the pres-
ence of trypsin as previously described (11).
EIAs for rotavirus antibodies. Sera and feces were exam-
ined for the presence of antirotaviral IgA, IgM, and IgG by
EIA, with SA11 virus as the antigen (22). Serum-specific IgG
was measured at a single dilution by direct EIA and was
expressed in units derived from a standard curve (5). In
serum, specific IgM titers were estimated by capture EIA
with affinity-purified goat anti-human IgM (TAGO Immuno-
globulins) as the coating reagent and monoclonal antibody to
rotavirus VP6 (13), conjugated to horseradish peroxidase to
detect virus bound via specific IgM. This eliminated the
problem of false-positive results that were observed with
some sera by using the direct IgM EIA (12). Serum IgA and
fecal antibodies (IgM and IgG) were titrated by a modifica-
tion of a direct EIA (22) in which sample dilutions were
incubated in virus-coated plates overnight at 4°C, skim milk
powder replaced bovine serum albumin to block background
reactions, and bound enzyme substrate was detected with
3,3'-5,5'-tetramethylbenzidine. Fecal extracts did not show
false-positive IgM titers by direct EIA. Fecal antirotaviral
IgA was estimated at a single dilution (1:100) of feces by
direct EIA and was expressed in units derived by computer
from log-logit analysis of data obtained from titration of a
reference fecal extract. These EIA systems for IgA, IgM,
and fecal IgG to rotavirus were described previously (12).
Definitions of immune conversions to rotavirus. IgG sero-
conversion was defined as an increase in EIA units per
milliliter of more than 30% between consecutive samples
from the same child (5). Seroconversion in IgA to rotavirus
was defined as a fourfold or greater rise in titer between
sequential samples. A positive IgM response in serum or
feces was defined as a titer equal to or greater than 1:200. An
IgA coproconversion was defined as a threefold increase in
EIA units per milliliter, to at least 100 units. These defini-
tions of conversions in IgA and IgM have been validated
(12).
Total IgA determination in feces. This assay was identical
to that described previously for measurement of total IgA in
neonatal breast milk (25). In brief, affinity-isolated, goat
anti-human IgA (TAGO) was employed as a coating reagent
and bound IgA was detected with the coating antibody,
which had been peroxidase conjugated (TAGO). The Aus-
tralian Serum Protein Standard, ASPS 78-1, a reference
preparation of human serum immunoglobulin, was tested in
serial fivefold dilutions on each plate. This data was used to
express the total IgA level in feces in units of micrograms per
milliliter, derived by computer from log-logit analysis, as
described previously for rotavirus-specific IgA estimation in
feces (12).
Calculation of specific IgA index. The ratio of the antirota-
viral IgA level in units per gram of stool to the total IgA level
in micrograms per gram of stool was designated as the
specific IgA index.
Definition and validation of significant increases in the IgA
index. Both specific and total IgA levels were estimated by
EIA in 795 fecal specimens collected from a subgroup of 19
children recruited into the study during 1984. These speci-
mens covered the first 101 to 495 (median, 420) days of
follow-up only. Twelve of these children showed a signifi-
cant rise (threefold increase to .100 units) in specific IgA
levels during the acute phase of their rotavirus gastroenteri-
tis. The IgA index in these 12 children increased from 4- to
39-fold (median, 16-fold) to a minimum of 8.1. In the seven
children in whom a rotavirus-specific IgA response was not
detected, the IgA index decreased up to 10-fold or increased
up to 3.8-fold (median, 5-fold decrease). Thus, an increase in
the IgA index from .4-fold to :>9-fold was defined as
significant in demonstrating later rotavirus infections.
Five additional episodes of diarrhea during which rotavi-
rus reinfection was detected occurred in the group of 44
children during surveillance. The fecal samples in which
total IgA was estimated covered three of these. In addition,
five episodes of diarrhea during which Giardia lamblia (2),
adenovirus (2), and an unidentified "small virus" (1) were
present were also identified. In each of the three episodes of
rotavirus diarrhea, specific IgA units, total IgA units, and the
specific IgA index increased significantly by 1 week follow-
ing the time of the diarrhea and virus detection. The specific
IgA units showed a greater increase (12- to 262-fold) than did
the total IgA units (1- to 10-fold), so that the IgA index was
elevated.
In contrast, no significant changes were detected in the
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ROTAVIRUS IgA COPROCONVERSION 1369
specific IgA units or in the specific IgA index during the five
nonrotaviral episodes of gastroenteritis, although the chil-
dren infected with G. lamblia and adenovirus all showed
increases in their total IgA levels.
Fluorescent focus reduction neutralization assay in feces.
The fluorescent focus reduction neutralization method was
adapted from that described previously for estimation of
rotavirus-neutralizing antibody levels in hybridoma superna-
tant fluids (11), and its development will be described
elsewhere (B. S. Coulson, and P. J. Masendycz, J. Clin.
Microbiol., in press). Rotavirus stocks (RV-4, Wa, Ku,
RV-5, RV-3, and ST-3) were activated with trypsin prior to
being incubated with fecal extracts. All extracts were re-
acted with each of the rotaviruses listed above. Stocks were
diluted to contain 2.5 x 104 fluorescing cell-forming units per
ml of rotavirus and 5 ,ug of porcine trypsin (Sigma Chemical
Co.) per ml in Dulbecco modified Eagle medium. After
incubation at 37°C for 30 min, the activated virus was further
diluted to 2.0 x 103 fluorescing cell-forming units per ml in
Dulbecco modified Eagle medium containing 1 ,ug of trypsin
per ml and 1% (vol/vol) fetal calf serum found to be free of
rotavirus antibodies by EIA and fluorescent focus reduction
neutralization assay (Dulbecco modified Eagle medium-
trypsin-fetal calf serum). The diluted virus was mixed with
an equal volume of fecal extract diluted 1:20 and 1:200 in
Dulbecco modified Eagle medium-trypsin-fetal calf serum in
duplicate, giving a final dilution of stool of 1:200 and 1:2,000,
respectively. The mixture was incubated at 37°C for 1 h, and
50 ,ul per well was inoculated in duplicate onto washed
confluent monolayers of MA104 cells in microdilution plates.
After centrifugation at 1,200 x g for 30 min, the plates were
incubated at 37°C in an atmosphere of 5% C02 and 95%
relative humidity overnight. The cell supernatants were
removed, and the monolayers were fixed in 70% (vol/vol)
acetone for 5 min and then were air dried. Rabbit hyperim-
mune antiserum to SA1l (50 ,lI) at optimal dilution (1:500) in
phosphate-buffered saline was added to each well, and the
plates were incubated at 37°C for 30 min. The plates were
washed in phosphate-buffered saline before addition of 25 ,ul
of fluorescein isothiocyanate-labeled sheep anti-rabbit IgG
F(ab')2 per well (Silenus, Australia) diluted 1:100 in phos-
phate-buffered saline. After 30 min at 37°C, the plates were
washed and air dried and wells were examined for specific
fluorescence, as described previously (11). The neutraliza-
tion titer of each fecal sample was expressed as the recipro-
cal of the fecal dilution giving 50% reduction in the number
of fluorescing cells. Fecal extracts (n = 40) containing no
antirotaviral IgA, IgM, or IgG by EIA all gave reciprocal
titers <200 by the fluorescent focus reduction neutralization
assay. Samples giving titers below 200 were therefore con-
sidered to be negative for neutralizing antibody to the
rotavirus being tested. A significant elevation in neutralizing
antibody, indicating rotavirus infection, was considered to
be a fourfold increase in titer to at least 1:400.
Statistical methodology. The paired Student t test was used
to test the significance of elevations in IgG and IgA levels
over time. Correlation between total IgA, specific IgA, and
the IgA index was tested by using Pearson's test on loga-
rithmically transformed data.
RESULTS
Of the 44 children recruited for follow-up, 4 withdrew
from the study after 6 months, so their data are not included
in this report. The remaining 40 children were monitored for
12 to 32 months (mean, 21 months). Samples were collected
from 26 (65%) children until the end of the first rotavirus
season after their initial infection (12 to 24 months; mean, 17
months) and from the remaining 14 children until the end of
their second rotavirus season following recruitment (24 to 32
months; mean, 29 months). For the purposes of this study,
the rotavirus season is considered to cover the six colder
months, i.e., from May to October.
Longitudinal analysis of rotavirus-specific antibody isotypes
in serum. Antirotaviral antibody fluctuations detected in
serum during the first 4 months of follow-up have been
previously reported (16). Since these fluctuations are con-
sidered to relate to the rotavirus infection which brought the
child to hospital, they are not considered in this analysis,
which describes antirotaviral antibody fluctuations observed
during the later 5 to 32 months of follow-up.
Of the 40 children monitored until the end of the first
rotavirus season after that in which they were recruited, 33
(83%) showed one (n = 23), two (n = 9), or three (n = 1)
seroconversions after the first 4 months of follow-up. These
seroconversions were detected in antirotaviral IgG only
(43%), IgA only (30%), or both IgG and IgA simultaneously
(27%). The overall seroconversion rate was 1.0 per child per
year. Of the 14 children monitored until the end of their
second rotavirus season, 9 (64%) showed a single serocon-
version. The antibody isotypes involved were both IgG and
IgA (56%) and IgG only (44%). The overall seroconversion
rate for the 14 children -n the 12 to 18 months including their
second season was 0.7 per child per year. The overall
seroconversion rate for the 40 children during the 2 to 3
years including two seasons was 0.8 per child per year.
Antirotaviral IgM was detected in only one child on one
occasion and was accompanied by a seroconversion in IgA.
Overall, 35 of the total 54 seroconversions were associated
with an episode of diarrhea (65%), including only 3 (5%) in
which rotavirus was detected in stools by EIA or EM.
Rotavirus was found in fecal specimens from two other
children without seroconversion (see below).
The geometric mean titers (IgA) and units (IgG) of antiro-
taviral antibodies measured in the serum samples of all 40
children studied are shown at 4-month intervals from recruit-
ment (Fig. 1). Large elevations in both IgG and IgA occurred
following the severe, presumably primary, episode of rota-
virus gastroenteritis. Further significant elevations in IgG
occurred between 12 and 16 months and between 24 and 28
months after the severe gastroenteritis (paired t test; P <
0.025 and P < 0.05, respectively). As the children were
recruited during the period from April to September in two
successive years, the increases in geometric mean titer of
specific IgG from 12 to 16 months and from 24 to 28 months
corresponded to the ends of the two successive winters
(rotavirus seasons) following the severe episode of rotavirus
gastroenteritis. A significant rise in the geometric mean titer
of specific IgA was recorded only between 4 and 8 months
after the severe gastroenteritis (paired t test; P < 0.05). The
rise in geometric mean titer of specific IgA from 12 to 16
months was not statistically significant (paired t test; P >
0.05).
Comparison of antirotaviral IgA units and the specific IgA
index for longitudinal analysis of rotavirus coproantibody.
There were 795 fecal specimens from 19 children in which
specific and total IgA levels were measured and the IgA
index was calculated. There was a weak but significant
correlation between specific and total IgA levels for each
fecal specimen (r, = 0.348; P < 0.01). However, the stronger
correlation was between specific IgA and the IgA index (r, =
0.743; P < 0.005). These results show that the measured
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FIG. 1. Geometric mean titers (IgA) and geometric mean units (IgG) of antirotaviral antibodies in sera of children at each 4-month interval
following hospitalization with rotavirus gastroenteritis. Symbols: *, IgG; O, IgA. Numbers refer to number of serum samples tested at each
time point.
variations in specific IgA in feces were not the result of
coincidental changes in total IgA concentration.
The specific IgA level and the IgA index calculated as
described previously are shown in Fig. 2 and 3 for two
representative children. The child represented in Fig. 2
showed very high levels of antirotaviral copro-IgA within 1
week of the onset of acute severe rotavirus gastroenteritis. A
peak was also detected in the total IgA levels, but at a lower
level, so the IgA index for this period was also significantly
elevated. Similarly, the elevation in antirotaviral copro-IgA
at day 80 was reflected in both the total IgA levels and the
IgA index.
Fluctuations in the levels of total IgA occurred from day
90 to day 460, unaccompanied by significant variations in the
other parameters. An extreme elevation in copro-IgA and
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IgA index at 480 days was due to rotavirus-associated
diarrhea but was not accompanied by any alteration in total
IgA levels.
Figure 3 represents a child, aged 21 months at hospitaliza-
tion, in whom no copro-IgA conversion or specific copro-
IgA was detected during hospitalization with acute rotavirus
gastroenteritis. Two secondary boosts in copro-IgA oc-
curred. The first, at day 80, was accompanied by a rise in the
IgA index, although total IgA levels were stable. The second
copro-IgA boost from days 250 to 260 was accompanied by
diarrhea and a significant elevation in both total IgA levels
and the IgA index.
Specific IgA coproconversions as defined here (see Mate-
rials and Methods) were detected in 24 instances from the
795 specimens collected from 19 children. These events were
440 480
NUMBER OF DAYS AFTER ONSET OF SEVERE ROTAVIRUS DIARRHEA
FIG. 2. Comparison of the profiles of antirotaviral IgA units, IgA indices, and levels of total IgA in stools of a 3-month-old child. C, IgA
coproconversion; O, diarrhea recorded. Symbols: *, diarrhea with rotavirus present in the stools; A, IgM detected in the stools. -----, IgG
seroconversion; ., IgA seroconversion.
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FIG. 3. Comparison of the profiles of antirotaviral IgA units, IgA indices, and levels of total IgA in the stools of a 21-month-old child.
Symbols are described in the legend to Fig. 2.
analyzed to determined whether or not specific IgA copro-
conversion was as sensitive a measure of rotavirus infection
as was the IgA index. Of 24 specific IgA coproconversions,
20 (83%) were associated with a significant rise in the IgA
index. Of these 20, 18 (90%) were also associated with other
measures of rotavirus infection (at least one of rotavirus in
stools, copro-IgM, seroconversion, or neutralizing antibody
coproconversion). Three of the four IgA coproconversions
not showing an elevated IgA index were also associated with
other markers of rotavirus infection. These coproconver-
sions did not show an elevated IgA index, since the total IgA
level was also increased. The false-negative and false-posi-
tive rates for specific copro-IgA conversion as a measure of
rotavirus infection were 5% (1 of 21) and 4% (1 of 24),
respectively. The IgA index showed a false-negative rate of
17% (4 of 24) and a false-positive rate of 5% (1 of 21). We
concluded that specific copro-IgA measurement alone was
more sensitive an estimate of rotavirus infection than was
the IgA index. Overall analysis of the longitudinal data was
thus performed with specific copro-IgA unit values only.
This avoided the need for total IgA estimation in all stools
collected.
Comparison of IgA coproconversion with conventional mea-
sures of rotavirus infection during rotavirus reinfection. Ro-
tavirus-specific copro-IgA units were estimated in all stool
specimens (3,150) collected from the 40 children (mean, 79
specimens per child) in whom antibody isotypes in serum
were studied. These specimens were also analyzed for the
presence of rotavirus by EM and EIA and for elevated levels
of copro-IgM to rotavirus. A subset of 422 fecal specimens
collected from 10 children (mean, 22 per child) was also
titrated for neutralizing antibody to rotaviruses RV-4, Wa,
Ku, RV-5, RV-3, and ST-3.
The 115 coproconversions recorded in the 3,150 stools
tested were accompanied by seroconversion in 61 cases
(53%), comprising IgG seroconversion alone (46%), IgA
seroconversion alone (28%), IgG and IgA seroconversion
(25%), and conversion in IgG, IgA, and IgM (1%). Serocon-
version in the absence of IgA coproconversion or any other
marker occurred on three occasions. The incidence of IgA
coproconversion with accompanying seroconversion was
not age related.
On all of the five occasions when copro-IgA conversions
were associated with the presence of rotavirus in stools, mild
to moderate diarrhea was recorded. Four cases were accom-
panied by seroconversion or copro-IgM. All 11 antirotaviral
IgM-containing stools also showed copro-IgA conversion.
Six (55%) were associated with seroconversion, and two
(18%) were associated with the presence of rotavirus in
stools. Copro-IgG to rotavirus was not detected in any stool
sample tested.
The relation of significant increases in neutralizing co-
proantibody against at least one rotavirus serotype to the
other markers of rotavirus infection tested is shown in Table
1. Although seroconversion, rotavirus detection, and copro-
conversion in IgM all showed a high predictive accuracy of
coproconversion in neutralizing antibody (92 to 100%), they
were insensitive markers, being present in only 4 to 46% of
neutralizing antibody coproconversions. In contrast, rotavi-
rus coproconversion in IgA was both a highly predictive
(92%) and sensitive (92%) marker of coproconversion in
rotavirus-neutralizing antibody. Two neutralizing antibody
conversions and one IgA coproconversion were not accom-
panied by any other marker of rotavirus infection.
Longitudinal analysis of rotavirus-specific IgA in stools.
Levels of specific copro-IgA units were estimated in stool
specimens collected from 40 children, the same population in
which antibody isotypes in serum were studied. Of the 40
children monitored for 12 to 18 months, including one
rotavirus season, 36 (90%) showed at least one coproconver-
sion. Up to 6 coproconversions per child were recorded,
TABLE 1. Comparison of rotavirus-neutralizing coproantibody
conversions with other markers of rotavirus reinfection
% (No. positive/no.
tested)
Source Marker
Sensitivity Predictive
accuracy
Serum Specific IgG conversion 29 (7/24) 88 (7/8)
Specific IgA conversion 33 (8/24) 100 (8/8)
Specific IgM conversion 4 (1/24) 100 (1/1)
Specific IgA, IgG, or IgM 46 (11/24) 92 (12/13)
conversion
Feces Rotavirus detected (EM or EIA) 4 (1/24) 100 (1/1)
Specific IgM conversion 13 (3/24) 100 (3/3)
Specific IgA conversion 92 (22/24) 92 (22/24)
a Sensitivity, Percentage of children with a neutralizing coproantibody
conversion who also had a particular marker at the given site.
b Predictive accuracy, Percentage of children with a particular marker at
the given site who also had a neutralizing coproantibody conversion.
c c
.. .........-......-......-----
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with a rate of 1.6 per child per year. Of the 14 children
monitored for 2 to 3 years, including two rotavirus seasons,
12 (86%) showed IgA coproconversions to rotavirus in the 12
to 18 months including the second season, ranging from 1 to
4 per child, with a rate of 1.7 per child per year.
The episode of severe rotaviral gastroenteritis which pro-
vided the starting point for longitudinal follow-up in the
children was probably a primary infection (16) as judged by
finding low or no rotavirus antibodies in acute-phase speci-
mens and by detecting IgM serum antibody in 100% of the
children. The peak level of specific copro-IgA was identified
where possible for each child producing copro-IgA following
the primary infection and each later copro-IgA conversion
(representing reinfection). Of the 97 pairs of primary and
reinfections, 79 (81%) showed greater peak copro-IgA levels
during the reinfections than during the primary infection. In
six of seven children with five to eight reinfections, the peak
copro-IgA level to rotavirus increased by two- to eightfold,
in a stepwise fashion from the first to the fourth or fifth
reinfection. Peak levels were lower during the last three or
four copro-IgA conversions, which occurred during the
second season of follow-up.
DISCUSSION
Infection of children with rotavirus is currently considered
proven if rotavirus particles or antigen are detected in stools
or if seroconversion in IgG, IgM, IgA, or neutralizing
antibody can be demonstrated. In severe acute gastroenteri-
tis where infection is usually primary, these criteria are
consistently met (5, 6, 10, 16, 17, 26, 29). However, rotavirus
infection is often mild or asymptomatic (5, 8, 15). In this
study, although all children excreted rotavirus during their
episode of acute rotaviral gastroenteritis, virus was detected
at the time of later IgA coproconversions on only five
occasions and was never found during IgA coproconversions
not accompanied by diarrhea. Concentration of fecal ex-
tracts by 10-fold and pretreatment with EDTA failed to
increase this number. All children studied had antirotaviral
IgA and IgG in serum, and rotavirus was not found in stools
containing high levels of antirotaviral copro-IgA. It is likely
that preexisting immunity may have kept virus growth in the
intestine to levels below the limits of detection by EIA and
EM. One of the rotavirus-positive diarrheal episodes oc-
curred during the brief hospitalization of the child for other
reasons, when all stools passed were obtained. Collection of
all stools during each diarrheal episode may improve virus
detection. When more sensitive antigen assays, perhaps
based on probes for viral RNA, are available, the fecal
samples of this study could be retested. In calves, experi-
mental secondary rotavirus infections resulted in immune
conversions in serum and feces but viral excretion was not
detected (3).
Seroconversion following rotavirus reinfection was de-
tected on 81 occasions, much more frequently than was
rotavirus antigen in stools. The major isotype involved was
IgG (58%), followed by IgA (41%) and IgM (1%). IgG and
IgA seroconversions occurred simultaneously in 75% of the
cases, and these antibodies persisted for prolonged periods.
In contrast, specific IgM was detected only once. All of
these children had shown an IgM immune response in serum
during their primary infection, with 91% responding in IgG
and 68% responding in IgA (16). The IgM levels during
primary infection peaked at least 6 days after onset and often
fell to baseline within 1 month. Sera may not have been
collected near enough to the time of rotavirus infection to
detect specific IgM in rotavirus reinfections not temporally
associated with diarrhea. However, serum was collected less
than 4 weeks after diarrhea in 44%, and less than 10 days
after diarrhea in 15%, of reported diarrheal episodes. Chil-
dren showed increasing numbers of rotavirus seroconver-
sions with increased length of follow-up, but these rarely
involved specific IgM.
At the end of each of the two successive rotavirus seasons
(winters) during which the children were studied, their
geometric mean levels of specific IgG rose significantly. This
suggests that reinfection with rotavirus also tended to be a
seasonal event and reflects our finding that most of the
children in the population studied seroconverted to rotavirus
each season. Similar IgG and IgA profiles with increasing
age were shown in the Federal Republic of Germany (7).
The children monitored for one complete rotavirus season
after recruitment showed a higher seroconversion rate (1.0
per child per year) than those monitored during their second
season (0.7 per child per year). The overall seroconversion
rate of 0.8 per child per year is similar to rates of infection
(0.3 to 1.2 episodes per child per year) reported in other
longitudinal studies in both developed and developing coun-
tries. These rates were calculated by using rotavirus detec-
tion and seroconversion in IgG or IgA or both by EIA (6, 26,
27, 29), rotavirus detection and seroconversion by indirect
immunofluorescence (17), and rotavirus detection alone (19,
21).
The weekly collection of stools from 44 children for 6 to 32
months has enabled us to study childhood antirotaviral
coproantibody profiles in great detail. Specific IgM was
rarely detected, and specific IgG was never found. Marked
fluctuations in specific copro-IgA, which were not the result
of coincidental changes in total IgA concentration, occurred
in many children, although total IgA levels were sometimes
elevated during proven rotavirus infections. Thus, use of the
IgA index, although giving similar results to specific copro-
IgA alone, was shown to be unnecessary to identify copro-
IgA conversion to rotavirus. In a small study, Hjelt et al. (18)
came to the same conclusion. The IgA index has been used
for rotavirus copro-IgA measurement without prior verifica-
tion (4, 23).
Analysis of the serum and mucosal antibody responses to
severe acute rotavirus gastroenteritis in these children
showed that copro-IgA, followed by serum IgA, were the
best predictors of duodenal IgA at 1 and 4 months after
infection (16). It is thus likely that the copro-IgA fluctuations
measured subsequently in this study, accompanied by virus-
neutralizing activity, reflect similar antibody changes in the
duodenum. This is the site at which virus-neutralizing anti-
bodies have been shown to exert protective capabilities in
animal models (24, 30).
All of the other markers of rotavirus infection tested
showed a high level of predictive accuracy in relation to
conversion in neutralizing coproantibody (92 to 100%).
However, the sensitivities of the markers in relation to
neutralizing coproantibody varied widely. Detection of co-
pro-IgM, virus in stools, or serum IgM was an insensitive
measure of coproconversion in neutralizing antibody. Sero-
conversion in IgG or IgA or both was a moderately sensitive
marker, being recorded in 46% of coproconversions. The
most sensitive marker, present in 92% of neutralizing anti-
body coproconversions, was rotavirus-specific copro-IgA
conversion.
Taken together with the validation of the unadjusted
rotavirus-specific IgA level as a reliable indicator of fluctu-
ations in rotavirus copro-IgA, the correlation of copro-IgA
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with neutralizing coproantibody suggests that coproconver-
sions represent true elevations in antirotaviral IgA with
neutralizing capacity. A coproconversion in IgA appears to
indicate genuine rotavirus infection. Without measurement
of neutralizing coproantibodies, Bernstein et al. (4) con-
cluded from a human rotavirus challenge study in adults that
increases in fecal antibody may be a reliable indicator of
rotavirus infection, even in the absence of detectable virus
shedding or seroconversion.
Taking coproconversion in specific IgA or neutralizing
antibody as the standard measure, this study shows that use
of seroconversion and virus detection only as measures of
rotavirus reinfection would lead to underestimation of virus
infection by approximately 200%. On the basis of the inci-
dence of coproconversion in IgA, the more accurate esti-
mate of rotavirus infection in this study is 1.6 per child per
year for the period covering the first rotavirus season and 1.7
per child per year for the period covering the second season
after recruitment. In contrast to that observed for serocon-
version rates, no drop in coproconversion rate in the second
season was observed, although the peak copro-IgA levels
recorded during the coproconversions were lower in the
second season than the first. It is likely that seroconversions
in the presence of already elevated serum IgA and IgG
rotavirus antibody levels are difficult to detect. Copro-IgA
levels often declined to baseline before a new coproconver-
sion was observed. Overall, 1.7 rotavirus coproconversions
per child per year were recorded in this study. This is in
excess of-the rates (0.3 to 1.2) determined in other reports (6,
17, 19, 21, 26, 27, 29), but coproconversions were not
measured in these studies. Shinozaki et al. (28) also reported
a rate of 1.7 rotavirus infections per child per year from
copro-IgA titer increases to rotavirus in seven children
tested monthly for 1 year.
Two of the five children excreting rotavirus and showing
copro-IgA conversions during reinfection did not serocon-
vert. This suggests that the mucosal and systemic antibody
responses to rotavirus can be unrelated, as was postulated
by Angeretti et al. (2).
The preliminary results from the longitudinal study indi-
cated that an anamnestic copro-IgA response, with higher
peak copro-IgA levels, occurred in 81% of rotavirus reinfec-
tions. Anamnestic responses in copro-IgA have been docu-
mented previously in five children with secondary rotavirus
infection (35) and in a larger group of children receiving
rhesus rotavirus vaccine (33).
Sufficient virus for serotyping was obtainable only from
one of the five children excreting rotavirus during reinfec-
tion, and this showed serotype 1 by monoclonal EIA (11;
Fig. 2, day 480). The primary infecting virus was also
serotype 1 (Fig. 2, day 3). It was not possible to determine
the infecting serotype from the increases in antibody levels
measured by EIA, as antigens of different serotypes (1 to 4)
gave similar EIA units and titers (12). During reinfection,
increases in neutralizing coproantibody titers usually oc-
curred to more than one serotype simultaneously, so this
method was also unsuitable for determining the serotype of
the infecting virus during reinfection.
In conclusion, the results of the study presented here
suggest that specific antirotaviral copro-IgA is a reliable
indicator of rotavirus reinfection and that it is a more
sensitive measure than is rotavirus detection or serocon-
version. Confirmation of this finding in children studied
longitudinally from birth in both developed and developing
countries is required. Measurement of rotavirus-specific
copro-IgA in stools, collected weekly during epidemiological
studies and vaccine trials, is likely to provide an accurate
estimation of rotavirus infection and may assist in the
measurement of vaccine take and vaccine efficacy.
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